pharmaphorum

APRIL 17, 2024

Learn about the importance of reshoring the UK pharmaceutical supply chain for future resilience. Discover how this strategic move can enhance local production and secure the availability of critical medications.

119

119

pharmaphorum

APRIL 2, 2024

Explore the innovative use of artificial intelligence (AI) and machine learning (ML) in securing the pharmaceutical supply chain for resilience and safety. Learn how cutting-edge technology is shaping the future of pharmaceutical logistics.

120

120

European Pharmaceutical Review

MARCH 11, 2024

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. In summary, considering the serious diseases caused by contaminated pharmaceuticals and the challenges discussed, Ahmed et al.

Sterile Compounds 87

Sterile Compounds Compounding Packaging Pharmaceutical Companies 87

European Pharmaceutical Review

JANUARY 9, 2024

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. AI and future perspectives: a glimpse into tomorrow Figure 2: adapted from Saha, G.

FDA 122

FDA 122

Pharmaceutical Technology

APRIL 22, 2024

Discover the groundbreaking patent granted to Recursion Pharmaceuticals Inc for compounds Formula (I) and (II) to treat diseases. Learn about the innovative pharmaceutical compositions and treatment methods.

Compounding 52

Compounding 52

European Pharmaceutical Review

MARCH 27, 2024

billion, exports of pharmaceuticals reached a total of 7.3 Value of Swedish pharmaceutical exports Swedish pharmaceuticals exports are currently “significantly larger” than exports of iron and steel. As such, Swedish pharmaceutical exports are expected to continue their positive development, SwedenBIO asserted.

88

88

BioPharm

APRIL 26, 2024

Contract manufacturer SK pharmteco will manufacture as well as conduct testing and release of Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firadenovec-vncg), a gene therapy for bladder cancer.

98

98

Pharmacy Times

APRIL 26, 2024

Camber Pharmaceuticals is thrilled to announce the addition of Aripiprazole Oral Solution to its product line, complementing the existing product family that included Aripiprazole Tablets.

65

65

Outsourcing Pharma

APRIL 17, 2024

Bormioli Pharma creates pharmaceutical packaging for drug stability, safety, and sustainability, partnering with global health leaders and says it stands at the forefront of sustainability.

Packaging 98

Packaging 98

Pharmafile

MAY 8, 2024

Biopharma company Mirum Pharmaceuticals has announced data from its phase 3 MARCH-PFIC study which evaluated maralixibat in patients with progressive familial intrahepatic cholestasis (PFIC). The post Mirum Pharmaceuticals publishes phase 3 MARCH maralixibat data in The Lancet appeared first on Pharmafile.

59

59

Pharmaceutical Technology

APRIL 11, 2024

Pharmaceutical Technology has listed the leading suppliers of pharmaceutical filtration equipment and purification solutions. Download here.

52

52

European Pharmaceutical Review

APRIL 15, 2024

Researchers investigating environmental microbial contamination found “no seasonal climatic influences were observed” in bacteria and fungi counts present in Grade D (ISO 8) Brazilian pharmaceutical cleanrooms. The paper was published in the Brazilian Journal of Pharmaceutical Sciences.

80

80

Pharmaceutical Technology

APRIL 19, 2024

Pharmaceutical Compliance Management Software Is Designed to Enhance Patient Safety. Download the Free Buyer’s Guide Here.

52

52

European Pharmaceutical Review

MARCH 28, 2024

The global pharmaceutical and biotechnology environmental monitoring market valued $24 billion in 2023, according to a report by Verified Market Research. As pharmaceutical and biotechnology companies grow, there is concurrent demand for regular environmental monitoring across new markets, the research explained. billion by 2030.

84

84

Pharmaceutical Technology

MAY 8, 2024

We look at the top six most important trends in pharmaceutical milling and how they are shaping the industry.

59

59

European Pharmaceutical Review

APRIL 19, 2024

The post Microbial burden assessment of solid pharmaceutical products appeared first on European Pharmaceutical Review. Overall, the validation results “could help to include water activity as a microbiological indicator for bioburden assessment of mesophyll, yeasts, and moulds, as well as objectionable microorganisms such as the B.

92

92

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. appeared first on European Pharmaceutical Review.

97

97

Pharmafile

APRIL 24, 2024

Eli Lilly and Nexus Pharmaceuticals have announced that they have entered into a definitive agreement for Eli Lilly to acquire a manufacturing facility from Nexus. The post Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals appeared first on Pharmafile.

59

59

European Pharmaceutical Review

DECEMBER 4, 2023

A report published by MarketsandMarkets has estimated that the pharmaceutical excipients market will value $14.9 However, considering growth potential, it was noted in the report that functional/multifunctional pharmaceutical excipients offer development opportunity within the sector. billion by 2028, growing at a CAGR of 6.8

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies 93

Pharmaceutical Technology

MARCH 1, 2024

Experts say that dry granulation is 10x more efficient than wet granulation, which could make substantial progress towards making this pharmaceutical process greener.

96

96

Pharmaceutical Technology

MARCH 28, 2024

View the Leading Pharmaceutical Compounding Companies in Contract Manufacturing for the Pharmaceutical Industry. Download Free Guide Here.

Compounding 52

Compounding 52

STAT

APRIL 29, 2024

Ono Pharmaceutical of Japan said Monday it will acquire Deciphera Pharmaceuticals, a Boston-based maker of cancer drugs, for $2.4   The all-cash deal values Diciphera at $25.60 per share, or a 75% premium to its Friday closing stock price.

114

114

Pharmaceutical Technology

MARCH 22, 2024

Discover Ironwood Pharmaceuticals' innovative patent for delayed release pharmaceutical compositions with linaclotide. Learn about the unique design and targeted therapeutic effects for gastrointestinal disorders.

52

52

Outsourcing Pharma

APRIL 2, 2024

Bora Pharmaceuticals Co., yesterday (April 1) finalized the acquisition of Upsher-Smith Laboratories, Inc., a leading generics manufacturer based in Minnesota, U.S., from its previous owners, Sawai Group Holdings and Sumitomo Corporation of Americas.

97

97

Pharmaceutical Technology

APRIL 22, 2024

Discover how BioMarin Pharmaceutical's patent for PAL variants offers a groundbreaking method to treat PKU in adolescents. Administering AvPAL variants weekly over 50 weeks effectively reduces blood phenylalanine levels.

96

96

Pharmig

APRIL 12, 2024

Discover why pharmaceutical microbiologists should routinely reflect on their careers and how this can benefit you now. The post Why It’s Important To Reflect on Your Pharmaceutical Microbiology Career appeared first on Pharmig. How’s your microbiology career going?

75

75

Pharmafile

APRIL 25, 2024

Prism BioLab has announced that it has entered into a target-exclusive research and licensing agreement with Ono Pharmaceutical. Once a candidate is identified, Prism is expected to license its right to Ono for […] The post Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement appeared first on Pharmafile.

64

64

Pharmaceutical Technology

APRIL 22, 2024

AST-001 is under clinical development by Ascentawits Pharmaceuticals and currently in Phase II for Esophageal Cancer.

96

96

Pharmaceutical Technology

APRIL 22, 2024

AST-001 is under clinical development by Ascentawits Pharmaceuticals and currently in Phase II for Rectal Cancer.

98

98

European Pharmaceutical Review

FEBRUARY 14, 2024

A report by Allied Market Research predicts that the global pharmaceutical suspension market will reach $83.8 The research specified that the parenteral administration sector accounted for more than half of the global pharmaceutical suspension market in 2022. billion by 2032. Having valued $55.5 percent between 2023 and 2032.

75

75

STAT

MARCH 25, 2024

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development. Now, Vertex may be on the move again.

108

108

European Pharmaceutical Review

APRIL 15, 2024

Hot-melt extrusion can help overcome many pharmaceutical formulation challenges since it is a straightforward technique to compound all excipients on a molecular level. The post ebook: Twin-screw extrusion for pharmaceutical applications appeared first on European Pharmaceutical Review. Interested to know more?

Dosage 59

Dosage Compounding 59

pharmaphorum

FEBRUARY 22, 2024

Discover how AI, automation, and blockchain technologies are revolutionising pharmaceutical case processing in compliance with FDA regulations. Explore the benefits of these advancements in this insightful article.

FDA 116

FDA 116

Pharmaceutical Technology

APRIL 24, 2024

Incyte has agreed to acquire US-based Escient Pharmaceuticals and its assets including two first-in-class small molecule antagonists targeting Mas-related G protein-coupled receptor X2 (MRGPRX2) for the treatment of various mast cell-mediated disorders.

59

59

European Pharmaceutical Review

JANUARY 29, 2024

1 Some five years after the initial NDMA (N-nitrosodimethylamine) contamination issue 2 initially affecting valsartan drug substance, then other active pharmaceutical ingredients (APIs), eg, sartans, ranitidine, metformin, etc; the toxic short alkyl chain N-nitrosamine issue appears, if not resolved, then well on the way to resolution.

FDA 100

FDA Vaccines Compounding 100

Pharmaceutical Technology

APRIL 22, 2024

AST-001 is under clinical development by Ascentawits Pharmaceuticals and currently in Phase II for Renal Cell Carcinoma.

97

97

European Pharmaceutical Review

MARCH 1, 2024

This Issue was brought to you in partnership with Fujifilm Irvine Scientific: The post <em>European Pharmaceutical Review </em> Issue 1 2024 appeared first on European Pharmaceutical Review.

64

64